Precise medicine of programmed cell death-1/programmed cell death 1 ligand 1 inhibitor immunotherapy combined radiotherapy for inoperable advanced lung cancer: A protocol for systematic review and meta-analysis

BACKGROUND: Programmed cell death-1/programmed cell death 1 ligand 1 (PD-1/PD-L1) inhibitors are a group of immune checkpoint inhibitors immunotherapy for cancer treatment. These immune checkpoint inhibitors are becoming first-line treatments for several types of cancer. Radiotherapy for cancer is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Gang, Lv, Xiaolan, Ding, Yanling, Guo, Yongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213331/
https://www.ncbi.nlm.nih.gov/pubmed/34128893
http://dx.doi.org/10.1097/MD.0000000000026367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213331/
https://www.ncbi.nlm.nih.gov/pubmed/34128893
http://dx.doi.org/10.1097/MD.0000000000026367

Ejemplares similares